In case of urgency, the Member State concerned may suspend the marketing of a medicinal product provided the Agency is informed at the latest on the following working day.
I hastetilfælde kan den berørte medlemsstat suspendere markedsføringen af et lægemiddel, forudsat at agenturet underrettes derom senest den følgende arbejdsdag.